Information on new approvals and medication safety that rheumatologists need to know
Search results for: juvenile idiopathic arthritis
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Panel Addresses Drug Safety Issues in Rheumatology Products
Black box warnings, TNF inhibitors, and tofacitinib discussed
ACR/ARHP Annual Meeting 2012: New Research Delves Into the Risk of Comorbidities for Patients with Lupus
Studying factors that may lead to life-threatening comorbidities such as lymphoma and thrombosis could give rheumatologists clearer direction on treating patients with SLE
The ACR Honors Contributions to Rheumatology
The American College of Rheumatology (ACR) recognizes a group of distinguished individuals for their contributions to rheumatology research, education, and patient care
Nomenclature, Semantics, Jargon, Lingo, Eponyms, Etymology, and Terminology in Rheumatology
Why rheumatologists must coin simple, comprehensible terms for what we read, speak and write to our patients
Partners in Advancing Rheumatology
The REF is making great strides in advancing treatment and finding cures for rheumatic disease.
Award Targets Critical Shortage of Pediatric Rheumatologists
Deborah Rothman, MD, PhD, received two separate ACR REF/Amgen Pediatric Rheumatology Visiting Professorship Awards, which allowed her to visit programs that do not have either a pediatric rheumatologist or a pediatric rheumatology fellowship program.
Information on New Drug Approvals and Medication Safety
Rheumatology-related drug safety, approvals, and what’s in the pipeline.
Data-Driven, Optimal Patient Care and Clinical Research
Expanded opportunities to advance rheumatology will be offered by ACR’s ongoing registry efforts
- « Previous Page
- 1
- …
- 29
- 30
- 31
- 32
- 33
- …
- 37
- Next Page »